Bci

02 Apr 23

Neuralink’s FDA Troubles Are Just the Beginning

Neuralink, the neurotechnology company founded by Elon Musk, is at best having a rough initial go-round with the Food and Drug Administration’s human-trials application process. The company also faces additional investigations by two other U.S. government agencies. These setbacks and the broad, cure-all expectations that its founder has placed on…
Read More
28 Mar 23

Neurotech’s Battles Impact Our Brains’ Future

Neurotechnologies today—devices that can measure and influence our brains and nervous systems—are growing in power and popularity. The neurotech marketplace, according to Precedence Research, is worth US $14.3 billion this year and will exceed $20 billion within four years. Noninvasive brain-computer interfaces, brain-stimulation devices, and brain-monitoring hardware (measuring alertness and…
Read More